Arterys Cardio DL vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Arterys Cardio DL

by Arterys (now part of Tempus)

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

Arterys Cardio DL specializes in detailed cardiac MRI analysis, offering automated ventricle segmentations and advanced blood flow visualization. In contrast, ClearRead CT focuses on cardiothoracic CT scans, providing AI-powered pulmonary nodule detection and coronary artery calcification scoring. While both enhance diagnostic workflows in radiology and cardiology, they cater to different imaging modalities and distinct clinical needs.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is advanced, AI-powered analysis of cardiac MRI studies. This cloud-based solution excels at automated ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement, significantly speeding up interpretation and improving diagnostic precision for complex cardiac MRI cases.

View Arterys Cardio DL →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on enhancing the detection and analysis of pulmonary nodules and coronary artery calcification within CT scans. This AI suite, with its patented vessel suppression technology, is ideal for streamlining radiology workflows and improving diagnostic accuracy for cardiothoracic CT examinations.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Arterys Cardio DL	ClearRead CT
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27]	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL (Tool A) emphasizes a cloud-based 'internet platform' with rapid analysis in seconds, significantly reducing interpretation time compared to traditional methods. The inclusion of editable automated contours also provides a user-friendly balance between automation and physician control, suggesting a highly streamlined workflow.

Clinical Value

ClearRead CT

While both tools are FDA-cleared and enhance diagnostic accuracy, ClearRead CT (Tool B) provides a specific, quantifiable clinical benefit: a '29% reduction in missed actionable nodules'. This concrete metric for improved detection accuracy offers a strong, evidence-based demonstration of its direct impact on patient care and diagnostic quality.

Pricing & Value

Tie

Both Arterys Cardio DL and ClearRead CT state 'contact for pricing' in their specifications. Without transparent or comparative pricing information, it is impossible to assess or differentiate their value propositions based on cost.

Enterprise Readiness

ClearRead CT

ClearRead CT (Tool B) offers both on-premise and cloud deployment options, providing greater flexibility to integrate into diverse enterprise IT infrastructures and security requirements. While both are FDA-cleared and claim HIPAA compliance, this deployment versatility gives Tool B an edge in accommodating various organizational needs.

Innovation

Arterys Cardio DL

Arterys Cardio DL (Tool A) positions itself as 'The world's first internet platform for medical imaging,' indicating a pioneering approach to cloud-native AI delivery in healthcare. This foundational innovation in platform architecture, combined with advanced features like 4D Flow post-processing, demonstrates a broader innovative vision beyond specific algorithmic improvements.

Support & Docs

Tie

The provided structured facts do not contain specific information regarding the quality, availability, or scope of support and documentation for either Arterys Cardio DL or ClearRead CT. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Arterys Cardio DL	ClearRead CT
Product Name	Arterys Cardio DL	ClearRead CT
Company	ARTERYS	RIVERAIN TECHNOLOGIES
Primary AI Application Focus	Automated, editable ventricle segmentations for cardiac MRI analysis	Pulmonary nodule detection and coronary artery calcification analysis in CT scans
Supported Specialties	Cardiology, Radiology	Cardiology, Pulmonology, Radiology
Key Feature Example 1	Automated ventricle segmentations for cardiac MRI	Pulmonary Nodule Detection (solid, part-solid, ground glass)
Key Feature Example 2	4D Flow post-processing for blood flow visualization and quantification	Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs)

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for Arterys Cardio DL versus ClearRead CT?

Arterys Cardio DL is designed for cardiac MRI analysis, providing automated ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement analysis. ClearRead CT, on the other hand, focuses on cardiothoracic CT scans, enhancing pulmonary nodule detection and coronary artery calcification analysis.

What specific features contribute to improved efficiency and accuracy for each tool?

Arterys Cardio DL drastically reduces cardiac MRI interpretation time from 30-60 minutes to seconds with automated, editable ventricle segmentations. ClearRead CT reduces reading times by up to 36% and improves detection accuracy by 29% in missed actionable nodules through patented Vessel Suppression and automated nodule tracking.

Which medical specialties are primarily targeted by each AI solution?

Arterys Cardio DL primarily serves Cardiology and Radiology, focusing on advanced cardiac MRI analysis. ClearRead CT targets Cardiology, Pulmonology, and Radiology, with its applications in pulmonary nodule detection and coronary artery calcification scoring from CT scans.

Do these tools offer capabilities for longitudinal tracking or comparison with prior exams?

Arterys Cardio DL focuses on rapid analysis of current cardiac MRI studies. ClearRead CT offers automated nodule tracking and comparison to prior exams, providing differential measurements for changes in pulmonary nodules over time.

What unique technological approaches do Arterys Cardio DL and ClearRead CT utilize?

Arterys Cardio DL leverages deep learning algorithms for automated ventricle segmentations and is noted as the first FDA-cleared cloud-based AI for medical imaging. ClearRead CT utilizes patented Vessel Suppression technology (Clear Visual Intelligence) to provide an unimpaired view of the lung, enhancing nodule conspicuity.